1. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype. King D, Yang G, Thompson MA, Hiebert SW (2002) Oncogene 21(32): 4978-82
    › Primary publication · 12118376 (PubMed)
  2. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. de Guzman CG, Warren AJ, Zhang Z, Gartland L, Erickson P, Drabkin H, Hiebert SW, Klug CA (2002) Mol Cell Biol 22(15): 5506-17
    › Primary publication · 12101243 (PubMed) · PMC133929 (PubMed Central)
  3. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Wang L, Hiebert SW (2001) Oncogene 20(28): 3716-25
    › Primary publication · 11439334 (PubMed)
  4. Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Hiebert SW, Lutterbach B, Amann J (2001) Curr Opin Hematol 8(4): 197-200
    › Primary publication · 11561155 (PubMed)
  5. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW (2001) Mol Cell Biol 21(19): 6470-83
    › Primary publication · 11533236 (PubMed) · PMC99794 (PubMed Central)
  6. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW (2001) Oncogene 20(8): 910-20
    › Primary publication · 11314026 (PubMed)
  7. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL (2001) Oncogene 20(48): 6983-93
    › Primary publication · 11704823 (PubMed)
  8. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J, Hiebert SW (2000) Cell Biochem Biophys 33(2): 199-207
    › Primary publication · 11325040 (PubMed)
  9. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW, Licht JD (2000) Mol Cell Biol 20(6): 2075-86
    › Primary publication · 10688654 (PubMed) · PMC110824 (PubMed Central)
  10. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW (2000) Mol Cell Biol 20(16): 5828-39
    › Primary publication · 10913166 (PubMed) · PMC86060 (PubMed Central)